By Christy Santhosh (Reuters) -AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments for autoimmune diseases. The U.S. drugmaker has spent over $20 billion on acquisitions since 2023 as its flagship rheumatoid arthritis drug, Humira, lost patent protection. Ca ...
SAO PAULO (Reuters) -Brazil’s government will launch an investigation into suspected export "dumping" of some hot-rolled steel products from China, India and Indonesia, its official gazette said on Monday. Preliminary studies have found the sufficient evidence of dumping as well as resulting damage to its domestic steel industry, the document said. Steelmakers in Latin America’s largest econom ...
Investing.com -- C3.ai Inc (NYSE:AI) stock rose 2.7% following the announcement of a strategic partnership with Huntington Ingalls Industries (NYSE:HII), America’s largest military shipbuilder, to expand digital technologies and apply artificial intelligence to accelerate shipbuilding throughput. The partnership aims to integrate AI solutions across HII’s shipbuilding operations, including pla ...
Investing.com -- Wolfe Research upgraded Medtronic plc to Peer Perform from Underperform saying that an expected ramp‑up of its Affera pulsed‑field ablation (PFA) system could add up to two percentage points to organic revenue and help the medical‑device maker exceed its own 5% growth target in fiscal 2026. Affera’s contribution means “everything else” would need to grow onl ...